Int J Biol Macromol. 2025 Jun 16. pii: S0141-8130(25)05848-9. [Epub ahead of print] 145293
Chronic wounds in diabetic patients pose significant clinical challenges due to persistent inflammation and impaired healing, leading to delayed closure and excessive scarring. Since chemokines play a pivotal role in inflammatory cell recruitment and scar formation, precise regulation of their activity and distribution is critical. Enteromorpha prolifera polysaccharides (PEPs) exhibit anti-inflammatory, antioxidant, and tissue regenerative properties closely associated with their sulfate group content. In this study, we developed three sulfated PEPs (SPEPs)-SPEP-L, SPEP-M, and SPEP-H-with varying sulfate contents. Our results demonstrated that all three SPEPs exhibited significant anti-inflammatory and anti-scarring activities, with efficacy positively correlated to their sulfate content. Mechanistic studies showed that SPEPs bind to chemokines via electrostatic interactions, thereby attenuating their aberrant signaling and accumulation. This dual action suppresses NF-κB activation, downregulates proinflammatory cytokines (e.g., TNF-α and IL-1β), and reprograms macrophages toward an anti-inflammatory phenotype, collectively reducing inflammatory cell infiltration and accelerating wound repair. Additionally, SPEPs regulated the TGF-β/Smad signaling pathway by modulating Smad2, Smad3, and Smad7 expression, thereby correcting abnormal collagen deposition and inhibiting early scar formation. These results suggest that sulfated PEPs enhance biological activity, effectively targeting inflammation and scarring through well-defined molecular mechanisms, thus promoting rapid and scar-free healing in diabetic wounds.
Keywords: Anti-inflammatory activity; Diabetic wound healing; Enteromorpha prolifera polysaccharide (PEP); Scar inhibition; Sulfate group modification